Section Arrow
Quote
ASBP.NASDAQ
- Aspire Biopharma Holdings Inc.
Quotes are at least 15-min delayed:2025/02/24 18:17 EST
Last
 2.05
-0.51 (-19.92%)
Day High 
2.1 
Prev. Close
2.56 
1-M High
15.8 
Volume 
1.07M 
Bid
1.97
Ask
2
Day Low
1.57 
Open
1.84 
1-M Low
2.5 
Market Cap 
117.60M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 10.02 
20-SMA 10.94 
50-SMA 11.42 
52-W High 15.8 
52-W Low 2.5 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.01/--
Enterprise Value
117.60M
Balance Sheet
Book Value Per Share
-0.02
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ADTXAditxt Inc0.0867-0.0048-5.25%0PE
PEPGPepGen2.2868+0.9168+66.92%-- 
RXRXRecursion Pharmaceuticals9-0.28-3.02%-- 
GERNGeron Corp2.385-0.185-7.20%-- 
OCEAOcean Biomedical0.12-0.0066-5.21%-- 
Quotes are at least 15-min delayed：2025/02/24 18:17 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tract.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.